Home › Pathophysiology › Hyperparathyroidism

Hyperparathyroidism

Hyperparathyreosis

For medical students2 min readUpdated 2026-10-10

Hyperparathyroidism is a pathological condition characterized by impaired function of the parathyroid glands. Depending on the underlying cause, the disease can be autonomous (originating within the glands themselves) or reactive (developing in response to disorders in other body systems).

Primary formCaused by pathology of the parathyroid glands themselves and their autonomous function

Secondary formArises as a reaction to kidney, intestinal, or bone tissue diseases

Tertiary formDevelops as a consequence of long-standing chronic secondary hyperparathyroidism

Primary Hyperparathyroidism

The primary form of the disease is always caused by a pathological process localized directly within the tissue of the parathyroid glands. The defining characteristic of this condition is the acquisition of autonomous function by the glands. This means their activity escapes the normal regulatory feedback loops of the body.

Key triggers initiating this process include structural changes in the glandular tissue:

Adenomas — the formation of benign tumors that uncontrollably secrete active substances.
Hyperplasia — diffuse pathological enlargement of the gland tissue.
Various neoplasms directly affecting the organ structure.

Secondary Hyperparathyroidism

Unlike primary disease, secondary forms are not caused by an initial defect within the glands themselves. This condition develops exclusively as a reaction to disorders in other organs and systems. The glands attempt to compensate for systemic imbalances, leading to reactive hyperactivity.

Among the most common causes provoking secondary hyperparathyroidism are:

Nephropathies — various kidney pathologies impairing normal renal function.
Intestinal pathology — gastrointestinal diseases leading to systemic metabolic shifts.
Osteopathies — primary bone tissue disorders.

Tertiary Hyperparathyroidism

Tertiary hyperparathyroidism is a predictable outcome of a long-standing pathological process. Its underlying mechanism is chronic secondary hyperparathyroidism.

If the reactive state (secondary form) persists in the body for a prolonged period, the glandular tissue undergoes irreversible changes. Persistent stimulation leads to the development of an adenoma, which eventually acquires autonomous function. Thus, a process that began as a reaction to extraglandular disease transforms into an independent pathology of the parathyroid glands.

Mnemonic

P-S-T Rule: Primary = Problem in the gland (autonomy), Secondary = Systemic/extraglandular (reaction to kidney/gut), Tertiary = Transformation of chronic Secondary into an autonomous adenoma.

Frequently asked questions

What is the pathogenesis of secondary hyperparathyroidism in chronic nephropathies?

The pathogenesis of secondary hyperparathyroidism in chronic nephropathies involves a deficiency of active vitamin D metabolites and phosphate retention.

Hyperphosphatemia — reduced renal phosphate excretion leads to phosphate accumulation and a drop in blood calcium levels.
Vitamin D deficiency — destruction of renal tissue causes decreased secretion of alpha-1-hydroxylase, impairing the conversion of inactive vitamin D to its active form and reducing calcium absorption.
Parathyroid hyperplasia — prolonged hypocalcemia and high phosphate levels stimulate the parathyroid glands to oversecrete parathyroid hormone (PTH).

What changes in blood calcium and phosphorus concentrations are characteristic of primary hyperparathyroidism?

Primary hyperparathyroidism is characterized by a simultaneous increase in blood calcium levels and a decrease in phosphorus levels.

Laboratory tests reveal:

Hypercalcemia — results from increased bone resorption and enhanced renal calcium reabsorption.
Hypophosphatemia — develops due to increased renal excretion of phosphates (hyperphosphaturia).

What clinical syndromes are distinguished in overt primary hyperparathyroidism?

Overt primary hyperparathyroidism presents with the following clinical syndromes and manifestations:

Dyspeptic syndrome — includes anorexia, nausea, vomiting, and weight loss.
Neuromuscular and psychiatric manifestations — accompanied by decreased neuromuscular excitability, muscle hypotonia, weakness, cramps, and depression.
Bone involvement — characterized by systemic osteoporosis, destructive cyst formation, and pathological fractures.
Visceropathic form — manifests as renal involvement (nephrolithiasis, nephrocalcinosis) and GI tract disorders (peptic ulcer disease, pancreatitis).

What specific bone changes are detected in hyperparathyroid osteodystrophy?

Hyperparathyroid osteodystrophy reveals signs of bone resorption, demineralization, and systemic osteoporosis.

Brown tumors (osteitis fibrosa cystica) — localized destructive cystic lesions.
Subperiosteal erosions — resorption of the cortical layer (typical for phalanges, tibia, and ribs).
Intracortical resorption — linear radiolucent areas, or cortical 'tunneling'.- Trabecular resorption — 'salt and pepper' skull appearance.
Rugger Jersey Spine — sclerosis of the vertebral endplates with central radiolucency.

How does blood calcium level change in secondary hyperparathyroidism of renal origin?

In secondary hyperparathyroidism of renal origin, blood calcium levels are decreased.

Prolonged hypocalcemia serves as the pathogenetic stimulus for the development of secondary hyperparathyroidism. In chronic kidney disease, phosphate excretion decreases, leading to hyperphosphatemia, which lowers serum Ca²⁺ and stimulates the parathyroid glands. Additionally, renal impairment reduces alpha-1-hydroxylase activity, decreasing the production of active vitamin D and impairing intestinal calcium absorption.

In tertiary hyperparathyroidism, which evolves from long-standing secondary disease, blood calcium levels become elevated.

What is the main difference between primary and secondary hyperparathyroidism?

In primary hyperparathyroidism, the source of the problem is within the parathyroid glands themselves (they function autonomously due to an adenoma or hyperplasia). Secondary hyperparathyroidism is merely a reactive response of healthy glands to diseases of other organs (such as the kidneys or intestines).

What is the mechanism of development of tertiary hyperparathyroidism?

Tertiary hyperparathyroidism develops on the background of chronic secondary hyperparathyroidism. Prolonged reactive stimulation of the glands leads to the formation of an adenoma that begins to function autonomously.

Which extraglandular pathologies most frequently cause secondary hyperparathyroidism?

The main causes of reactive hyperparathyroidism include nephropathies (kidney diseases), various intestinal pathologies, and osteopathies (bone tissue lesions).

Go deeper

Pathogenesis of parathyroid adenoma formation
Mechanisms of autonomous secretion in hyperplasia
Link between nephropathies and secondary hyperparathyroidism
Role of intestinal pathology in reactive states
Morphological transformation of glands during transition from secondary to tertiary form